Search

Ryan N. Henderson

Examiner (ID: 2057, Phone: (571)270-1430 , Office: P/3779 )

Most Active Art Unit
3795
Art Unit(s)
3739, 3795, 3779
Total Applications
931
Issued Applications
516
Pending Applications
102
Abandoned Applications
329

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5526777 [patent_doc_number] => 20090196854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'METHODS AND COMPOSITIONS FOR USE OF CRL 5803 CELLS FOR EXPRESSION OF BIOTHERAPEUTICS AND ENCAPSULATED CELL-BASED DELIVERY' [patent_app_type] => utility [patent_app_number] => 12/025392 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 41211 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20090196854.pdf [firstpage_image] =>[orig_patent_app_number] => 12025392 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/025392
METHODS AND COMPOSITIONS FOR USE OF CRL 5803 CELLS FOR EXPRESSION OF BIOTHERAPEUTICS AND ENCAPSULATED CELL-BASED DELIVERY Feb 3, 2008 Abandoned
Array ( [id] => 1076863 [patent_doc_number] => 07615374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions' [patent_app_type] => utility [patent_app_number] => 12/024770 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4266 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615374.pdf [firstpage_image] =>[orig_patent_app_number] => 12024770 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/024770
Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions Jan 31, 2008 Issued
Array ( [id] => 4866802 [patent_doc_number] => 20080145861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Methods of protein production in cell lines' [patent_app_type] => utility [patent_app_number] => 12/012387 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13215 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145861.pdf [firstpage_image] =>[orig_patent_app_number] => 12012387 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/012387
Methods of protein production in cell lines Jan 31, 2008 Issued
Array ( [id] => 6143480 [patent_doc_number] => 20110129928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'Method of Manufacturing Induced Pluripotent Stem Cell Originated from Somatic Cell' [patent_app_type] => utility [patent_app_number] => 12/865690 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4881 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129928.pdf [firstpage_image] =>[orig_patent_app_number] => 12865690 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/865690
Method of Manufacturing Induced Pluripotent Stem Cell Originated from Somatic Cell Jan 30, 2008 Abandoned
Array ( [id] => 4739970 [patent_doc_number] => 20080233623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'GENETICALLY MODIFIED HOST CELLS FOR INCREASED P450 ACTIVITY LEVELS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/021974 [patent_app_country] => US [patent_app_date] => 2008-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23954 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233623.pdf [firstpage_image] =>[orig_patent_app_number] => 12021974 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/021974
GENETICALLY MODIFIED HOST CELLS FOR INCREASED P450 ACTIVITY LEVELS AND METHODS OF USE THEREOF Jan 28, 2008 Abandoned
Array ( [id] => 5379316 [patent_doc_number] => 20090191155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'COMPOSITIONS AND METHODS FOR AMELIORATING MYOSIN VIIA DEFECTS' [patent_app_type] => utility [patent_app_number] => 12/021078 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16637 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191155.pdf [firstpage_image] =>[orig_patent_app_number] => 12021078 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/021078
Compositions and methods for ameliorating myosin VIIa defects Jan 27, 2008 Issued
Array ( [id] => 4837641 [patent_doc_number] => 20080134352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Method for producing transgenic rats' [patent_app_type] => utility [patent_app_number] => 12/011762 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14481 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20080134352.pdf [firstpage_image] =>[orig_patent_app_number] => 12011762 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/011762
Method for producing transgenic rats Jan 27, 2008 Issued
Array ( [id] => 5379330 [patent_doc_number] => 20090191169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Methods for gene transfer to mammals' [patent_app_type] => utility [patent_app_number] => 12/010426 [patent_app_country] => US [patent_app_date] => 2008-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6753 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191169.pdf [firstpage_image] =>[orig_patent_app_number] => 12010426 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/010426
Method for transforming a hair follicle Jan 23, 2008 Issued
Array ( [id] => 8528030 [patent_doc_number] => 08304601 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Mouse model for eye disease' [patent_app_type] => utility [patent_app_number] => 12/524268 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 6506 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524268 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/524268
Mouse model for eye disease Jan 22, 2008 Issued
Array ( [id] => 6062122 [patent_doc_number] => 20110200579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO' [patent_app_type] => utility [patent_app_number] => 12/375668 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 61460 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200579.pdf [firstpage_image] =>[orig_patent_app_number] => 12375668 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/375668
NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO Jan 21, 2008 Abandoned
Array ( [id] => 6513831 [patent_doc_number] => 20100011455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'STEM CELL GENE TARGETING' [patent_app_type] => utility [patent_app_number] => 12/523632 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10898 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20100011455.pdf [firstpage_image] =>[orig_patent_app_number] => 12523632 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/523632
Targeting the Rosa26 gene in human embryonic stem cells Jan 17, 2008 Issued
Array ( [id] => 4873833 [patent_doc_number] => 20080200567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'IN VIVO SCREENING MODELS FOR TREATMENT OF ALZHEIMER\'S DISEASE AND OTHER QPCT-RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/016266 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 21736 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200567.pdf [firstpage_image] =>[orig_patent_app_number] => 12016266 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/016266
IN VIVO SCREENING MODELS FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER QPCT-RELATED DISORDERS Jan 17, 2008 Abandoned
Array ( [id] => 8870356 [patent_doc_number] => 08465732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/523372 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 13812 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12523372 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/523372
Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof Jan 17, 2008 Issued
Array ( [id] => 4794212 [patent_doc_number] => 20080295186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Neurotrypsin overexpressing animal' [patent_app_type] => utility [patent_app_number] => 12/007928 [patent_app_country] => US [patent_app_date] => 2008-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7283 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0295/20080295186.pdf [firstpage_image] =>[orig_patent_app_number] => 12007928 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/007928
Neurotrypsin overexpressing animal Jan 16, 2008 Abandoned
Array ( [id] => 314523 [patent_doc_number] => 07524491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Non human animals with human-glial chimeric brains' [patent_app_type] => utility [patent_app_number] => 12/015372 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13893 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524491.pdf [firstpage_image] =>[orig_patent_app_number] => 12015372 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/015372
Non human animals with human-glial chimeric brains Jan 15, 2008 Issued
Array ( [id] => 4820340 [patent_doc_number] => 20080226611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Gene Therapy Using TGF-beta' [patent_app_type] => utility [patent_app_number] => 12/014715 [patent_app_country] => US [patent_app_date] => 2008-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10318 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226611.pdf [firstpage_image] =>[orig_patent_app_number] => 12014715 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/014715
Gene Therapy Using TGF-beta Jan 14, 2008 Abandoned
Array ( [id] => 5508446 [patent_doc_number] => 20090081653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Insulin-responsive DNA binding proteins-1 and methods to regulate insulin-responsive genes' [patent_app_type] => utility [patent_app_number] => 12/008962 [patent_app_country] => US [patent_app_date] => 2008-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 89 [patent_figures_cnt] => 89 [patent_no_of_words] => 37821 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081653.pdf [firstpage_image] =>[orig_patent_app_number] => 12008962 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/008962
Insulin-responsive DNA binding proteins-1 and methods to regulate insulin-responsive genes Jan 14, 2008 Issued
Array ( [id] => 5416412 [patent_doc_number] => 20090042299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Vectors and methods for tissue specific synthesis of proteins in eggs of transgenic hens' [patent_app_type] => utility [patent_app_number] => 12/008399 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8971 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042299.pdf [firstpage_image] =>[orig_patent_app_number] => 12008399 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/008399
Vectors and methods for tissue specific synthesis of proteins in eggs of transgenic hens Jan 8, 2008 Abandoned
Array ( [id] => 5435616 [patent_doc_number] => 20090170203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'METHODS FOR FEMALE MAMMALIAN SPERMATOGENESIS AND MALE MAMMALIAN OOGENESIS USING SYNTHETIC NANOBIOLOGY' [patent_app_type] => utility [patent_app_number] => 11/968180 [patent_app_country] => US [patent_app_date] => 2008-01-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16548 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170203.pdf [firstpage_image] =>[orig_patent_app_number] => 11968180 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/968180
METHODS FOR FEMALE MAMMALIAN SPERMATOGENESIS AND MALE MAMMALIAN OOGENESIS USING SYNTHETIC NANOBIOLOGY Dec 31, 2007 Abandoned
Array ( [id] => 5522208 [patent_doc_number] => 20090030189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'mTOR GLS and ELS, their small molecule mimetics and competitive inhibitors' [patent_app_type] => utility [patent_app_number] => 12/001161 [patent_app_country] => US [patent_app_date] => 2007-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9314 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030189.pdf [firstpage_image] =>[orig_patent_app_number] => 12001161 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/001161
mTOR GLS and ELS, their small molecule mimetics and competitive inhibitors Dec 9, 2007 Abandoned
Menu